CANADIAN-BASED·RESEARCH USE ONLY

Recovery & Healing

LL-37 Explained: The Antimicrobial Peptide Researchers Continue to Study

Peptideology Research Team5 min read
LL-37 Explained: The Antimicrobial Peptide Researchers Continue to Study

Discover cathelicidin LL-37, a critical component of the human innate immune system, and its broad-spectrum antimicrobial and wound-healing properties under research scrutiny.

Introduction

LL-37 is a 37-amino acid peptide belonging to the cathelicidin family of host defense peptides. It is the only known human cathelicidin and plays a critical role in the innate immune response - the body's first line of defense against pathogenic invasion.

What Is LL-37?

LL-37 is derived from the hCAP18 precursor protein, which is cleaved by proteases (primarily serine protease) to release the active 37-amino acid peptide. It is produced by epithelial cells, neutrophils, macrophages, and NK cells - tissues at the interface of the body's innate immune defense.

Mechanism of Antimicrobial Action

LL-37 disrupts the integrity of bacterial membranes through a carpet mechanism or toroidal pore formation. Its amphipathic alpha-helical structure allows it to insert into and disrupt the phospholipid bilayer of gram-positive and gram-negative bacteria, as well as certain fungi and viruses.

Immune Modulation

Beyond direct antimicrobial activity, LL-37 acts as an immune modulator. It binds to and neutralizes lipopolysaccharide (LPS), reducing septic shock risk. It also recruits macrophages, promotes dendritic cell maturation, and stimulates angiogenesis through VEGF receptor activation.

Wound Healing Research

LL-37 is found at elevated concentrations at sites of skin injury. Research has demonstrated that it promotes keratinocyte migration and proliferation, angiogenesis, and re-epithelialization - processes essential for wound closure and tissue restoration.

Anti-Cancer Research

An emerging line of research investigates LL-37's dual relationship with cancer. In some contexts it exhibits anti-tumor activity; in others it may promote tumor angiogenesis. This complexity makes it a subject of active and ongoing investigation in oncology research models.

Conclusion

LL-37 occupies a unique position in research biology - straddling immunology, microbiology, wound healing, and oncology. Its multifunctional nature and natural origin from the human innate immune system continue to drive interest across multiple research disciplines.

For Research Use Only. All compounds mentioned in this article are sold strictly for in-vitro laboratory research. They are not intended for human or veterinary diagnostic, therapeutic, or clinical use.

Frequently Asked Questions

More in Recovery & Healing